The Howard Hughes Medical Institute has announced that it will invest $200 million in a group of biomedical scientists who are pushing the boundaries of biomedical research and advancing our understanding of cells, brains, metabolism, and more.
Each of the nineteen researchers will receive up to $8 million over seven years, which is renewable pending a scientific review of their work. In addition, each investigator will be guaranteed a two-year transition period. The first HHMI investigators ever to receive seven-year terms, the researchers in the program's inaugural cohort were selected from a pool of six hundred and seventy-five applicants and are based at fifteen different institutions in the U.S.
They include Beth Shapiro, an evolutionary molecular biologist at the University of California, Santa Cruz whose work, including her book How to Clone a Mammoth, is focused on the analysis of ancient DNA; Ralph DeBerardinis, a professor at the Children's Medical Research Institute at the University of Texas Southwestern Pediatrics whose research has improved the lives of children living with metabolic diseases; and Jesse Bloom, an evolutionary biologist at the Fred Hutchinson Cancer Research Center whose research has uncovered genetic secrets that could help fight influenza.
"Every scientist is unique, but they all need one thing: time," said HHMI president Erin O'Shea. "HHMI is dedicated to providing outstanding biomedical scientists with the time and resources to do their best work. We think of this as investing in people, not just projects."